4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-046788
VP, Chief Accounting Officer acquired 1,530 shares (other)
- VP, Chief Accounting Officer gave up 191 shares (to pay taxes)
- VP, Chief Accounting Officer acquired 552 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peraza Lisa VP, Chief Accounting Officer | 2021-04-30 | Other acquisition | +1,530 | $13.90 | $21,263 | 13,475 | D: show line 1 in the form |
| Peraza Lisa VP, Chief Accounting Officer | 2021-07-13 | Option exercise | +552 | 14,027 | D: show line 2 in the form | ||
| Peraza Lisa VP, Chief Accounting Officer | 2021-07-13 | Shares withheld for taxes | −191 | $13.48 | $2,575 | 13,836 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peraza Lisa VP, Chief Accounting Officer | 2021-07-13 | Option exercise · Restricted Stock Units | −552 | 7,177 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…